IL6 and neoplasm: Correspondingly, following rhIL-37 administration to the induced RCC model in male severe combined immune deficiency (SCID) mice, the tumor volume and weight were significantly declined, accompanied by obvious reduced staining intensity of proliferation antigen Ki-67 and the expression of IL-6 and HIF-1α in the tumor tissue.